GRHL3 and depressive symptom measurement: The pathway consists of 5-hydroxytryptamine (5-HT) projections from the dorsal raphe nucleus to somatostatin (SOM)-expressing and non-SOM interneurons in the central nucleus of the amygdala, which continue to extend directly towards the lateral habenula, an area known to be involved in depression.